Ligand validation:1IGX

COH: PROTOPORPHYRIN IX CONTAINING CO

COH is a Ligand Of Interest in 1IGX designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1IGX_COH_A_601	8%	12%	0.265	0.742	2.15	1.91	12	14	1	1	100%	1
1IGZ_COH_A_601	44%	14%	0.166	0.893	2.01	1.86	14	13	2	1	100%	1
1DIY_COH_A_601	32%	17%	0.151	0.824	1.84	1.8	11	12	1	1	100%	1
1U67_COH_A_601	11%	17%	0.273	0.787	1.86	1.79	10	14	4	1	100%	0.75
9F5U_COH_A_901	98%	5%	0.065	0.987	1.77	3.42	12	30	1	1	100%	0.9692
9FVS_COH_A_901	97%	4%	0.067	0.985	1.91	3.6	10	28	0	1	100%	0.9584
2ZDP_COH_A_200	92%	24%	0.091	0.98	1.39	1.74	4	14	1	1	100%	1
2O5S_COH_X_154	91%	9%	0.087	0.975	2.35	2.19	16	16	0	1	100%	1
2O5T_COH_X_154	91%	7%	0.086	0.972	2.52	2.27	18	19	1	1	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.